Adaptive Biotechnologies Corp (NAS:ADPT)
$ 4.61 0.31 (7.21%) Market Cap: 679.85 Mil Enterprise Value: 436.43 Mil PE Ratio: 0 PB Ratio: 2.81 GF Score: 75/100

Adaptive Biotechnologies Corp at Cowen Health Care Conference (Virtual) Transcript

Mar 09, 2022 / 02:50PM GMT
Release Date Price: $12.82 (+9.57%)
Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Research Analyst

Good morning. Welcome to Day 3 of the Cowen Healthcare Conference. I'm Dan Brennan, one of the tools and diagnostics analyst here. Really pleased to be joined with me on the virtual stage here, Chad Robins, Co-Founder, CEO, Chairman of Adaptive Bio. I have known Chad for a while. So first off, just, Chad, welcome and thanks for being here.

Chad M. Robins
Adaptive Biotechnologies Corporation - Co-Founder, CEO & Chairman

Hey Dan, thanks for having me. It's great to be back at Cowen.

Questions & Answers

Daniel Gregory Brennan
Cowen and Company, LLC, Research Division - Research Analyst

Awesome. So I'd like to kick it off just with the news out today a couple of announcements. So first, Tycho Peterson, the new CFO. Secondly, you announced the reorientation of the business under MRD and immune medicine, which have been discussed and then also a workforce reduction. So first, on Tycho, that's awesome. He's going to be

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot